Invezz

Quantum Cyber (QUCY)

Nasdaq Market Open

Quantum Cyber N.V. is a publicly traded company focused on opportunities where quantum computing and cybersecurity overlap. Its strategy is built around the expectation that advances in quantum technology will reshape how sensitive data is protected, particularly for governments, financial institutions, communications networks, healthcare systems, energy assets, and other critical infrastructure operators.

The company’s market focus reflects a growing concern across the cybersecurity industry: sufficiently powerful quantum computers could eventually weaken or break widely used public-key encryption methods. In response, organisations are assessing post-quantum cryptography, quantum-safe key management, secure communications architectures, and other defensive tools designed to protect information over long time horizons. Quantum Cyber positions itself within this transition, seeking to develop or assemble a diversified platform that addresses emerging security risks before they become mainstream operational threats.

As an investment story, Quantum Cyber is tied less to a single established product line and more to a developing theme at the intersection of deep technology and cyber resilience. The company’s prospects depend on its ability to identify commercially relevant quantum-security applications, form partnerships, build credible technical capabilities, and convert demand for quantum-safe protection into revenue. This places it in a market that can be attractive but also highly specialised, with long adoption cycles and meaningful technology uncertainty.

For investors, Quantum Cyber N.V. represents exposure to a niche segment of the broader cybersecurity sector, centred on the future need to secure digital infrastructure against quantum-era attacks.

2.27 USD
−0.16 (-6.50%)

Last updated

Market Cap
P/E
P/FCF
P/S
Enterprise Value
Sector
Health Care
Industry
Pharmaceutical Preparations
Address
ROBERT KOCH STRASSE 50, MAINZ, 2M, 55129

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q1 2024 Q4 2023 Q4
Revenue
Gross profit
Operating income -2.46M -2.75M
EBITDA -2.41M 0 -2.58M 0 0
Net income -5.08M -5M
Basic EPS -0.43 -1.46
Diluted EPS -0.43 -1.46

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q1 2024 Q4 2023 Q4
Total assets 7.72M 5.33M 13.5M 15.41M
Total liabilities 3.13M 4.69M 7.5M 12.16M
Total equity 4.59M 641.6K 6M 3.25M
Cash & equivalents 4.45M 701.6K 6.24M 7.07M
Current assets 6.6M 4.21M 8.02M 8.98M
Current liabilities 1.04M 857.56K 6.18M 9.24M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q1 2024 Q4 2023 Q4
Operating cash flow -2.71M -3.94M
Investing cash flow -650.66K -198.04K
Financing cash flow 7.27M -356.96K
Change in cash 3.86M -4.4M
Kind Filing Date Link
edgar index DEF 14A — Quantum Cyber N.V. View Filing
edgar index ARS — Quantum Cyber N.V. View Filing
edgar index 8-K — Quantum Cyber N.V. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — Quantum Cyber N.V. View Filing
edgar index 4 — Quantum Cyber N.V. View Filing
eight k text 8-K — 8-K View Filing
edgar index PRE 14A — Quantum Cyber N.V. View Filing
edgar index 144 — Quantum Cyber N.V. View Filing
edgar index 4 — Quantum Cyber N.V. View Filing
edgar index 3 — Quantum Cyber N.V. View Filing
form 3 Form 3 — O'Rourke Peter View Filing
edgar index 8-K — Quantum Cyber N.V. View Filing
edgar index 144 — Quantum Cyber N.V. View Filing
eight k text 8-K — 8-K View Filing
edgar index 10-Q — Quantum Cyber N.V. View Filing
edgar index 8-K — Quantum Cyber N.V. View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — NATAN DAVID View Filing
form 4 Form 4 — Ben-Tzvi Avraham View Filing
edgar index 4 — Quantum Cyber N.V. View Filing
edgar index 8-K — Quantum Cyber N.V. View Filing
edgar index 3 — Quantum Cyber N.V. View Filing
edgar index 3 — Quantum Cyber N.V. View Filing
edgar index SCHEDULE 13D — Quantum Cyber N.V. View Filing
eight k text 8-K — 8-K View Filing
form 3 Form 3 — NATAN DAVID View Filing
form 3 Form 3 — Ben-Tzvi Avraham View Filing
form 4 Form 4 — Lazar David E. View Filing
form 4 Form 4 — Lazar David E. View Filing
form 4 Form 4 — Lazar David E. View Filing
edgar index 8-K — MAINZ BIOMED N.V. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — MAINZ BIOMED N.V. View Filing
edgar index DEF 14A — MAINZ BIOMED N.V. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — MAINZ BIOMED N.V. View Filing
eight k text 8-K — 8-K View Filing
edgar index PRE 14A — MAINZ BIOMED N.V. View Filing
edgar index 8-K — MAINZ BIOMED N.V. View Filing
eight k text 8-K — 8-K View Filing
edgar index 3 — MAINZ BIOMED N.V. View Filing
edgar index 4 — MAINZ BIOMED N.V. View Filing
form 3 Form 3 — Lazar David E. View Filing
edgar index S-8 — MAINZ BIOMED N.V. View Filing
edgar index 3 — MAINZ BIOMED N.V. View Filing
edgar index 4 — MAINZ BIOMED N.V. View Filing
edgar index 4 — MAINZ BIOMED N.V. View Filing
edgar index 4 — MAINZ BIOMED N.V. View Filing
edgar index 4 — MAINZ BIOMED N.V. View Filing
form 3 Form 3 — Hekland Hans View Filing
form 3 Form 3 — Hekland Hans View Filing
form 3 Form 3 — Hekland Hans View Filing
form 3 Form 3 — Hekland Hans View Filing
form 3 Form 3 — Hekland Hans View Filing
edgar index SCHEDULE 13G/A — MAINZ BIOMED N.V. View Filing
edgar index 8-K — MAINZ BIOMED N.V. View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — Lazar David E. View Filing
form 4 Form 4 — Lazar David E. View Filing
form 4 Form 4 — Lazar David E. View Filing
form 4 Form 4 — Lazar David E. View Filing
form 4 Form 4 — BAECHLER GUIDO View Filing
form 4 Form 4 — Tibbitts Gregory J View Filing
form 4 Form 4 — Dreismann Heinrich View Filing
form 4 Form 4 — Caragol William J View Filing
edgar index 8-K — MAINZ BIOMED N.V. View Filing
edgar index 3 — MAINZ BIOMED N.V. View Filing
edgar index 3 — MAINZ BIOMED N.V. View Filing
edgar index 3 — MAINZ BIOMED N.V. View Filing
edgar index 3 — MAINZ BIOMED N.V. View Filing
form 3 Form 3 — BAECHLER GUIDO View Filing
form 3 Form 3 — BAECHLER GUIDO View Filing
form 3 Form 3 — BAECHLER GUIDO View Filing
form 3 Form 3 — BAECHLER GUIDO View Filing